Clinical Trial Update: Precise Treatment for BLIS Subtype of TNBC in the First-line Treatment of Locally Advanced or Metastatic Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating a BLIS subtype-specific treatment for first-line locally advanced or metastatic triple-negative breast cancer is currently recruiting. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Snippet

Sponsor: Fudan University | Conditions: Triple-Negative Breast Cancer | Phase 3 | Status: RECRUITING